Publication: Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
Issued Date
2021-01-01
Resource Type
ISSN
14661861
09629351
09629351
Other identifier(s)
2-s2.0-85102649739
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Mediators of Inflammation. Vol.2021, (2021)
Suggested Citation
Niti Kumari, Somrudee Reabroi, Brian J. North Unraveling the Molecular Nexus between GPCRs, ERS, and EMT. Mediators of Inflammation. Vol.2021, (2021). doi:10.1155/2021/6655417 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76397
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
Author(s)
Other Contributor(s)
Abstract
G protein-coupled receptors (GPCRs) represent a large family of transmembrane proteins that transduce an external stimulus into a variety of cellular responses. They play a critical role in various pathological conditions in humans, including cancer, by regulating a number of key processes involved in tumor formation and progression. The epithelial-mesenchymal transition (EMT) is a fundamental process in promoting cancer cell invasion and tumor dissemination leading to metastasis, an often intractable state of the disease. Uncontrolled proliferation and persistent metabolism of cancer cells also induce oxidative stress, hypoxia, and depletion of growth factors and nutrients. These disturbances lead to the accumulation of misfolded proteins in the endoplasmic reticulum (ER) and induce a cellular condition called ER stress (ERS) which is counteracted by activation of the unfolded protein response (UPR). Many GPCRs modulate ERS and UPR signaling via ERS sensors, IRE1α, PERK, and ATF6, to support cancer cell survival and inhibit cell death. By regulating downstream signaling pathways such as NF-κB, MAPK/ERK, PI3K/AKT, TGF-β, and Wnt/β-catenin, GPCRs also upregulate mesenchymal transcription factors including Snail, ZEB, and Twist superfamilies which regulate cell polarity, cytoskeleton remodeling, migration, and invasion. Likewise, ERS-induced UPR upregulates gene transcription and expression of proteins related to EMT enhancing tumor aggressiveness. Though GPCRs are attractive therapeutic targets in cancer biology, much less is known about their roles in regulating ERS and EMT. Here, we will discuss the interplay in GPCR-ERS linked to the EMT process of cancer cells, with a particular focus on oncogenes and molecular signaling pathways.